AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25577300 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (150 mg capsules, twice daily for three months)
Number of subjects: 60
Study 24252844 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg daily
Number of subjects: 143
Study 24252844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 21325137 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg daily for 8 weeks)
Number of subjects: 24
Study 19363221 — intervention group
Group type: EXPERIMENTAL
Intervention: Plerixafor with G-CSF
Number of subjects: 302
Study 19363221 — intervention group
Group type: COMPARATOR
Intervention: Placebo with G-CSF
Number of subjects: 302
Study 17531579 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril add-on therapy
Number of subjects: 1832
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind biopsy alone
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopy with biopsy
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation including transvaginal ultrasound
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipelle sampler
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Tao brush
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: No investigation (low-risk group)
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy alone (moderate-risk group)
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopy (high-risk group)
Number of subjects: 0
Study 15361316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (low-risk group)
Number of subjects: 0
Study 11568544 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan pediatric cough syrup (1 mg/kg)
Number of subjects: 40
Study 11568544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9458249 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet pressure of 350 mmHg
Number of subjects: 28
Study 9458249 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet pressure of 100 mmHg plus systolic blood pressure
Number of subjects: 28
Study 7696449 — intervention group
Group type: COMPARATOR
Intervention: Pancrease (4 capsules t.d.s.)
Number of subjects: 13
Study 7696449 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancrease-HL (1 capsule t.d.s.)
Number of subjects: 13
Study 3673204 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast-derived hepatitis B vaccine (YDV)
Number of subjects: 778
Study 3673204 — intervention group
Group type: COMPARATOR
Intervention: Commercial plasma-derived vaccine (PDV)
Number of subjects: 778
Study 30507045 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced suctioning of the mouth and oropharynx every 4 hours
Number of subjects: 400
Study 30507045 — intervention group
Group type: COMPARATOR
Intervention: Usual care (sham suctioning)
Number of subjects: 400
Study 29019891 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel silicone finger cap
Number of subjects: 22
Study 29019891 — intervention group
Group type: COMPARATOR
Intervention: Traditional film dressing
Number of subjects: 22
Study 25858203 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy for 8 weeks
Number of subjects: 33
Study 25858203 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy utilizing positive psychology strategies
Number of subjects: 33
Study 23075433 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser therapy adjunct to scaling and root planing (SRP)
Number of subjects: 35
Study 23075433 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 35
Study 19962771 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 12035
Study 19962771 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 12035
Study 19066612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led follow-up (n=54)
Number of subjects: 109
Study 19066612 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up (n=55)
Number of subjects: 109
Study 17959037 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of celecoxib and octreotide
Number of subjects: 75
Study 17959037 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 75
Study 15050264 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp-edged hydrophobic acrylic IOL (AMO Sensar OptiEdge AR40e)
Number of subjects: 72
Study 15050264 — intervention group
Group type: COMPARATOR
Intervention: Round-edged hydrophobic acrylic IOL (AMO Sensar AR40)
Number of subjects: 72
Study 15050264 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone IOL (Pharmacia CeeOn 911A) with polished capsule
Number of subjects: 72
Study 15050264 — intervention group
Group type: COMPARATOR
Intervention: Silicone IOL (Pharmacia CeeOn 911A) with unpolished capsule
Number of subjects: 72
Study 11329494 — intervention group
Group type: EXPERIMENTAL
Intervention: EtOH 0.8 g/kg
Number of subjects: 27
Study 11329494 — intervention group
Group type: EXPERIMENTAL
Intervention: AMP 20 mg
Number of subjects: 27
Study 11329494 — intervention group
Group type: EXPERIMENTAL
Intervention: AMP 10 mg
Number of subjects: 27
Study 11329494 — intervention group
Group type: EXPERIMENTAL
Intervention: EtOH 0.8 g/kg and AMP 20 mg
Number of subjects: 27
Study 11329494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 10186967 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS membrane with autogenous bone chips
Number of subjects: 19
Study 10186967 — intervention group
Group type: COMPARATOR
Intervention: Control group (without membrane, using periosteum)
Number of subjects: 19
Study 8052880 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (RT), 60 Gy in 30 fractions over 6 weeks
Number of subjects: 92
Study 8052880 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated RT, 60 Gy in 30 fractions over 3 weeks
Number of subjects: 92
Study 8052880 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional RT plus carboplatin 70 mg/m2/d on days 1 to 5 during treatment weeks 1 and 5
Number of subjects: 92
Study 8052880 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated RT plus carboplatin 70 mg/m2/d on days 1 to 5 of week 1 only
Number of subjects: 92
Study 8052880 — intervention group
Group type: COMPARATOR
Intervention: All study arms
Number of subjects: 92
Study 2564724 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, 80 mg twice daily
Number of subjects: 10
Study 2564724 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilevalol, 400 mg once daily
Number of subjects: 10
Study 2564724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29619682 — intervention group
Group type: EXPERIMENTAL
Intervention: RP5063
Number of subjects: 175
Study 28949820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 60
Study 28949820 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF
Number of subjects: 60
Study 28949820 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 25622823 — intervention group
Group type: COMPARATOR
Intervention: UHC
Number of subjects: 495
Study 25622823 — intervention group
Group type: EXPERIMENTAL
Intervention: UHC + NP
Number of subjects: 495
Study 25622823 — intervention group
Group type: EXPERIMENTAL
Intervention: UHC + NP + HC
Number of subjects: 495
Study 23023310 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic medial branch blocks (MBB)
Number of subjects: 61
Study 23023310 — intervention group
Group type: EXPERIMENTAL
Intervention: <50% pain relief after MBB
Number of subjects: 61
Study 23023310 — intervention group
Group type: EXPERIMENTAL
Intervention: Any MBB pain relief cutoff over 50%
Number of subjects: 61
Study 21765229 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (Group 1)
Number of subjects: 77
Study 21765229 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program combined with joint and soft tissue mobilization (Group 2)
Number of subjects: 77
Study 21765229 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐based rehabilitation program (Group 3)
Number of subjects: 77
Study 19958964 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 2868
Study 19958964 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 2868
Study 16703602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 267
Study 16703602 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 267
Study 16703602 — intervention group
Group type: COMPARATOR
Intervention: Community mental health referral
Number of subjects: 267
Study 16703602 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD subgroup (comorbid PTSD)
Number of subjects: 267
Study 16703602 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct treatment of PTSD
Number of subjects: 267
Study 15210047 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micro g of misoprostol vaginally 6 h before dilatation and curettage
Number of subjects: 44
Study 15210047 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginally 6 h before dilatation and curettage
Number of subjects: 44
Study 11280890 — intervention group
Group type: EXPERIMENTAL
Intervention: Once a day administration of terazosin (2 mg)
Number of subjects: 42
Study 11280890 — intervention group
Group type: COMPARATOR
Intervention: Twice a day administration of terazosin (2 mg)
Number of subjects: 42
Study 9248765 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol valerate (4 mg)
Number of subjects: 9
Study 9248765 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone (40 mg)
Number of subjects: 9
Study 9248765 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 9
Study 1945609 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Illness Observation Scales (AIOS)
Number of subjects: 369
Study 1945609 — intervention group
Group type: COMPARATOR
Intervention: Three-point global assessment scale (Control)
Number of subjects: 369
Study 6807679 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa
Number of subjects: 308
Study 6807679 — intervention group
Group type: EXPERIMENTAL
Intervention: VM26
Number of subjects: 308
Study 6807679 — intervention group
Group type: COMPARATOR
Intervention: Control (TUR only)
Number of subjects: 308
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: eFACE scores of the palpebral fissure at rest before eyelid weight placement (84.3 [15.9]) vs after (109.7 [21.4])
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: eFACE scores with gentle eyelid closure before eyelid weight placement (65.9 [28.0]) vs after (92.1 [15.4])
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: eFACE scores with forceful eyelid closure before eyelid weight placement (75.1 [28.6]) vs after (97.0 [10.7])
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotrics measurements of palpebral fissure at rest before eyelid weight placement (10.3 [2.2]) vs after (9.1 [1.8])
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotrics measurements with gentle eyelid closure before eyelid weight placement (4.4 [2.7]) vs after (1.3 [2.0])
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotrics measurements with forceful eyelid closure before eyelid weight placement (3.0 [3.1]) vs after (0.5 [1.3])
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of patients with expected recovery (n=40) showed eFACE scores before (83.9 [22.7]) vs after (98.9 [4.4]) eyelid weight placement
Number of subjects: 53
Study 31095257 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of patients with no expected recovery (n=13) showed improvement in both eFACE and Emotrics analysis after eyelid weight placement
Number of subjects: 53
Study 27317436 — intervention group
Group type: EXPERIMENTAL
Intervention: Galaxy COPD model
Number of subjects: 0
Study 25959707 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 36
Study 25959707 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 23928295 — intervention group
Group type: EXPERIMENTAL
Intervention: ∆9-tetrahydrocannabinol (THC)
Number of subjects: 11
Study 23928295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 21333272 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted CBT (CA-CBT)
Number of subjects: 24
Study 21333272 — intervention group
Group type: COMPARATOR
Intervention: Applied muscle relaxation (AMR)
Number of subjects: 24
Study 19896184 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine strategy for chest radiographs
Number of subjects: 849
Study 19896184 — intervention group
Group type: COMPARATOR
Intervention: On-demand strategy for chest radiographs
Number of subjects: 849
Study 17126768 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum 2 capsules twice daily (2 x 10^9 CFU per capsule) for 10 weeks
Number of subjects: 46
Study 17126768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 17126768 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus fermentum and Placebo
Number of subjects: 46
Study 14972339 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 73
Study 14972339 — intervention group
Group type: COMPARATOR
Intervention: Categorical Scale (CT)
Number of subjects: 73
Study 11303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal criteria for pelvic inflammatory disease (CDC recommendations)
Number of subjects: 651
Study 11303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Adnexal tenderness
Number of subjects: 651
Study 11303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive test result for Chlamydia trachomatis or Neisseria gonorrhoeae
Number of subjects: 651
Study 11303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinations of clinical criteria
Number of subjects: 651
Study 9850033 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenograstim 2 microg/kg daily
Number of subjects: 52
Study 9850033 — intervention group
Group type: COMPARATOR
Intervention: Lenograstim 5 microg/kg daily
Number of subjects: 52
Study 7826820 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 11
Study 7826820 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol with L-NMMA infusion
Number of subjects: 11
Study 7826820 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 11
Study 7826820 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol with PGF2 alpha preconstriction
Number of subjects: 11
Study 3400680 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose regimen: 5 g mezlocillin plus 2 g cefoperazone intravenously every four hours
Number of subjects: 0
Study 3400680 — intervention group
Group type: COMPARATOR
Intervention: Lower dose regimen: 3 g mezlocillin plus 1 g cefoperazone intravenously every four hours
Number of subjects: 0
Study 3400680 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose regimen
Number of subjects: 0
Study 3400680 — intervention group
Group type: COMPARATOR
Intervention: Lower dose regimen
Number of subjects: 0
Study 28844431 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE (coordinated specialty care intervention)
Number of subjects: 0
Study 28844431 — intervention group
Group type: COMPARATOR
Intervention: CC (usual community care)
Number of subjects: 0
Study 26650226 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based questionnaire (WBQ)
Number of subjects: 128
Study 26650226 — intervention group
Group type: COMPARATOR
Intervention: No questionnaire (Control)
Number of subjects: 128
Study 25769911 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 655066 (any dose)
Number of subjects: 39
Study 25769911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 23796210 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp with hybrid iterative reconstruction algorithm level of 40% (i-100 kVp)
Number of subjects: 110
Study 23796210 — intervention group
Group type: COMPARATOR
Intervention: 120 kVp with hybrid iterative reconstruction algorithm level of 60% (i-120 kVp)
Number of subjects: 110
Study 20097781 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance/strength training for 6 weeks
Number of subjects: 16
Study 20097781 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched subjects)
Number of subjects: 16
Study 18174457 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 3986
Study 18174457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3986
Study 16758238 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 45
Study 16758238 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (40 mg)
Number of subjects: 45
Study 16758238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 12751880 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based preventive intervention (Botvin, G. J. 1996, 2000)
Number of subjects: 847
Study 11192620 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (20 2s 20 Hz stimulations at 80% motor threshold over 20 min, dorsolateral prefrontal cortex)
Number of subjects: 12
Study 11192620 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 8752198 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 0
Study 8447207 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose solution before surgery and Ringer‐acetate during surgery
Number of subjects: 14
Study 8447207 — intervention group
Group type: COMPARATOR
Intervention: No glucose before and during surgery (starved)
Number of subjects: 14
Study 8447207 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose before surgery and Ringer‐acetate during surgery
Number of subjects: 14
Study 8447207 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer‐acetate alone or Ringer‐acetate plus 10% glucose
Number of subjects: 14
Study 3510947 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 34
Study 3510947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Difference (MD)
Number of subjects: 20
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoverlap of All Pairs (NAP)
Number of subjects: 20
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of Nonoverlapping Data (PND)
Number of subjects: 20
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted Randomized Alternation Design (RRAD)
Number of subjects: 20
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely Randomized Design (CRD)
Number of subjects: 20
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Block Design (RBD)
Number of subjects: 20
Study 28389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated Data Types
Number of subjects: 20
Study 27615039 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertiveness training applying Dongsasub training (4 sessions)
Number of subjects: 63
Study 25007405 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Response Team (RRT) intervention
Number of subjects: 286
Study 25007405 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 286
Study 23512256 — intervention group
Group type: EXPERIMENTAL
Intervention: Umesh's intubation detector
Number of subjects: 100
Study 20628312 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of hypertonic saline-epinephrine (HSE) solution (1 mL) 1 to 2-cm oral to the papilla
Number of subjects: 120
Study 20628312 — intervention group
Group type: COMPARATOR
Intervention: No injection (noninjection group)
Number of subjects: 120
Study 17938425 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m2 on day 1 plus gemcitabine 1 gm/m2 on days 1 and 8 (arm A)
Number of subjects: 512
Study 17938425 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin at AUC of 6 mg on day 1 plus gemcitabine 1 gm/m2 on days 1 and 8 (arm B)
Number of subjects: 512
Study 17938425 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Survival (OS)
Number of subjects: 512
Study 17938425 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year survival
Number of subjects: 512
Study 17938425 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective Response (OR)
Number of subjects: 512
Study 17938425 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to Progression (TtP)
Number of subjects: 512
Study 17938425 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxicity
Number of subjects: 512
Study 17002741 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative oral care including tooth brushing, denture cleaning, and tongue cleaning
Number of subjects: 30
Study 17002741 — intervention group
Group type: COMPARATOR
Intervention: Control group (only gargled with povidone iodine)
Number of subjects: 30
Study 17002741 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative oral care
Number of subjects: 30
Study 12728025 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal activation of knee muscles in female athletes
Number of subjects: 52
Study 12728025 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports involving jumping and pivoting maneuvers
Number of subjects: 52
Study 10801169 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured attention
Number of subjects: 241
Study 10801169 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnotic relaxation
Number of subjects: 241
Study 10801169 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 241
Study 8633674 — intervention group
Group type: EXPERIMENTAL
Intervention: CUSA 200 cavitational ultrasonic surgical aspirator (group 1, 20 patients)
Number of subjects: 40